Tissue Tranglutaminase (Ttg) Test Market: By Type (Serological, Biopsy, and others), and By End Users (Hospitals & Clinics, Homecare, Research Organisations, others) - Global Forecast Till 2027
Market Highlights
The tissue transglutaminase (tTG) testing is used for the diagnosis of certain autoimmune diseases, which is mostly restricted to celiac disease. In celiac disease, gluten (a protein found in wheat, barley, rye, and oats) is seen as a foreign invader and in response to it the body mounts an immune response to its enacting enzyme known as transglutaminase (which restricts the proteolysis of the glutin). tTG enzyme gets attacked by the (tTG) IgA and (tTG) IgG. For diagnostic purposes (tTG) IgA is exploited more frequently than the tTG (IgG) as tTG (IgG).
Increasing prevalence of celiac disease drives the growth of the market. According to the World Gastroenterology Organization in 2016, 1% of the total population in western countries was diagnosed with the celiac diseases and the prevalence have substantially increased across the globe. According to Celiac Disease Foundation in 2016, hospitalization have increased by 600% from 1998 to 2013.
Increasing prevalence of autoimmune diseases mainly celiac disease, increasing geriatric global pool, and increasing investments healthcare drives the market growth. Low healthcare expenditure in developing regions, costs considerations, false positive diagnosis in geriatric population marked due to conditions such as diarrhoea, etc. likely to affect the market growth negatively.
Global tTG testing Market
Some of key players profiled in the report are Quest Diagnostics Incorporated., SQI Diagnostics, Trinity Biotech, ZEDIRA GmbH, Demeditec Diagnostics GmbH, ARUP Laboratories, Cell Science Systems, Bio-Rad Laboratories, Inc., Pfizer Inc., Celimmune, LLC., and others.
Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/824
Regional Analysis
The Americas account for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new technology in the US drives the global tTG testing market. Additionally, concentration of major research companies and research organizations in the developed countries of this region boost the market growth.
Europe is the second largest market in the world due to high income and healthcare penetration.
Asia Pacific region is expected to grow rapidly. China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.
Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.
Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “global tissue transglutaminase testing market” research report – Forecast till 2023.
Segmentation
The global tissue transglutaminase testing market has been segmented on the basis types and end users.
Based on types, the market has been segmented into serological, biopsy testing, and others. The serological testing is sub-segmented into tissue transglutaminase (tTG) antibody- IgA, serum and tissue transglutaminase (tTG) antibody- IgG, serum.
Based on the end users, the market has been segmented as hospitals & clinics, homecare, research organizations, and others.
Table Of Contents
1. Report Prologue
2. Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Mega Trends
4.5 Macroeconomic Indicators
5. Market Factor Analysis
5.1 Value Chain Analysis
5.2 Porters Five Forces
5.3 Demand & Supply: Gap Analysis
5.4 Pricing Analysis
5.5 Investment Opportunity Analysis
5.6 Merger And Acquisition Landscape
5.7 Upcoming Trends
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/tissue-transglutaminase-test-market-824
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Related Report:
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
Tissue Tranglutaminase (Ttg) Test Market: By Type (Serological, Biopsy, and others), and By End Users (Hospitals & Clinics, Homecare, Research Organisations, others) - Global Forecast Till 2027Market HighlightsThe tissue transglutaminase (tTG) testing is used for the diagnosis of certain autoimmune diseases, which is mostly restricted to celiac disease.
tTG enzyme gets attacked by the (tTG) IgA and (tTG) IgG.
According to the World Gastroenterology Organization in 2016, 1% of the total population in western countries was diagnosed with the celiac diseases and the prevalence have substantially increased across the globe.
According to Celiac Disease Foundation in 2016, hospitalization have increased by 600% from 1998 to 2013.Increasing prevalence of autoimmune diseases mainly celiac disease, increasing geriatric global pool, and increasing investments healthcare drives the market growth.
likely to affect the market growth negatively.Global tTG testing MarketSome of key players profiled in the report are Quest Diagnostics Incorporated., SQI Diagnostics, Trinity Biotech, ZEDIRA GmbH, Demeditec Diagnostics GmbH, ARUP Laboratories, Cell Science Systems, Bio-Rad Laboratories, Inc., Pfizer Inc., Celimmune, LLC., and others.
Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/824Regional AnalysisThe Americas account for a significant market share owing to extensive use of medications and high expenditure on the health care.
Tissue Tranglutaminase (Ttg) Test Market: By Type (Serological, Biopsy, and others), and By End Users (Hospitals & Clinics, Homecare, Research Organisations, others) - Global Forecast Till 2023The Tissue Tranglutaminase (Ttg) Test Market report offers insights into the leading market players and presents an assessment of their current market position.
Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M activities, and the latest R initiatives is also available in the reportMajor Key PlayersThe key strategies followed by the players operating in the global Tissue Tranglutaminase (Ttg) Test Market were innovation, product development, acquisition, and expansion.Quest Diagnostics Incorporated., SQI Diagnostics, Trinity Biotech, ZEDIRA GmbH, Demeditec Diagnostics GmbH, ARUP Laboratories, Cell Science Systems, and Bio-Rad Laboratories, Inc., Pfizer Inc., Celimmune, LLC., and others.Market Segment AnalysisThe global tissue transglutaminase testing market has been segmented on the basis types and end users.Based on types, the market has been segmented into serological, biopsy testing, and others.
The serological testing is sub-segmented into tissue transglutaminase (tTG) antibody- IgA, serum and tissue transglutaminase (tTG) antibody- IgG, serum.Based on the end users, the market has been segmented as hospitals & clinics, homecare, research organizations, and others.Top of FormKey Study Highlights:This report for Tissue Tranglutaminase (Ttg) Test Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance.The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market.
The report also gives a broad study of the different market segments and regions.Regional AnalysisGeographically, the global Tissue Tranglutaminase (Ttg) Test Market has been divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.Browse Full Report Page Enabled with complete Table of Content at https://www.marketresearchfuture.com/reports/tissue-transglutaminase-test-market-824Chapter 9.
Global Tissue Tranglutaminase (Ttg) Test Market By Region9.1 Introduction9.2 America9.2.1 North America9.2.1.1 U.S.9.2.1.2 Canada9.2.2 South America9.3 Europe9.3.1 Western Europe9.3.1.1 Germany9.3.1.2 France9.3.1.3 Italy9.3.1.4 Spain9.3.1.5 U.K.9.3.1.6 Rest Of Western Europe9.3.2 Eastern Europe9.4 Asia Pacific9.4.1 Japan9.4.2 China9.4.3 India9.4.4 Australia9.4.5 Republic Of Korea9.4.6 Rest Of Asia Pacific9.5 The Middle East & Africa9.5.1 United Arab Emirates9.5.2 Saudi Arabia9.5.3 Oman9.5.4 Kuwait9.5.5 Qatar9.5.6 Rest Of The Middle East & AfricaAbout Market Research Future: MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.Contact:+1 646 845 9312 | Email: [email protected]
